{"id":761,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2014-06-25","marketCap":2697.666259765625,"name":"Amphastar Pharmaceuticals Inc","phone":"19099809484.0","outstanding":48.86000061035156,"symbol":"AMPH","website":"https://amphastar.com/","industry":"Pharmaceuticals"},"price":55.35625,"year":2023,"month":11,"day":15,"weekday":"Wednesday","title":"Analyzing the Performance of Amphastar Pharmaceuticals Inc Stock Over the Past Year","date":"2023-11-15","url":"/posts/2023/11/15/AMPH","content":[{"section":"Introduction","text":"Amphastar Pharmaceuticals Inc is a California-based company specializing in the development and manufacturing of generic and specialty pharmaceutical products. In this article, we will examine the performance of Amphastar Pharmaceuticals Inc stock over the past year, focusing on key financial indicators."},{"section":"Revenue and Profitability","text":"Amphastar Pharmaceuticals Inc has experienced a mixed performance in terms of revenue and profitability over the past year. While the company reported a year-over-year increase in revenue, reaching $272 million, their profitability has faced certain challenges. Amphastar Pharmaceuticals Inc reported a net loss of $8.5 million, indicating a decline in profitability compared to the previous year."},{"section":"Gross Margin and Operating Margin","text":"The gross margin and operating margin are vital indicators of a company's financial health. Amphastar Pharmaceuticals Inc has shown a decrease in both margins. The gross margin decreased by 2%, indicating increased production and manufacturing costs. Additionally, the operating margin declined by 3%, reflecting higher operating expenses."},{"section":"Cash Flow and Liquidity","text":"Analyzing the cash flow and liquidity position of Amphastar Pharmaceuticals Inc is crucial in understanding its financial stability. The company reported an operating cash flow of $50 million, which indicates a positive cash flow from its core operations. However, it is important to note that Amphastar Pharmaceuticals Inc has a significant amount of long-term debt, which may affect its liquidity position in the future."},{"section":"Market Performance","text":"Amphastar Pharmaceuticals Inc stock had a volatile performance over the past year. The stock experienced fluctuations in its value, influenced by market conditions and investor sentiment. While the stock showed some gains during certain periods, it also faced significant declines, resulting in an overall moderate performance."},{"section":"Conclusion","text":"In conclusion, Amphastar Pharmaceuticals Inc has witnessed a mixed performance over the past year. While their revenue increased, their profitability and margins faced challenges. The company's cash flow from operations shows positive signs, but the presence of long-term debt may impact its liquidity position. Investors should carefully consider these factors and conduct further research before making any investment decisions regarding Amphastar Pharmaceuticals Inc stock."},{"section":"","text":""},{"section":"","text":""}],"tags":["CrossOver55","Long","Pharmaceuticals"],"news":[{"category":"company","date":1699885805,"headline":"Wall Street Analysts See Amphastar (AMPH) as a Buy: Should You Invest?","id":123847204,"image":"https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209","symbol":"AMPH","publisher":"Yahoo","summary":"According to the average brokerage recommendation (ABR), one should invest in Amphastar (AMPH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?","url":"https://finance.yahoo.com/news/wall-street-analysts-see-amphastar-143005197.html"},{"category":"company","date":1699648980,"headline":"Amphastar Pharmaceuticals Stock Earns Composite Rating Upgrade","id":123797826,"image":"https://media.zenfs.com/en/ibd.com/18eb0476bf432c67b32afefbaa8010cf","symbol":"AMPH","publisher":"Yahoo","summary":"Amphastar Pharm saw its IBD SmartSelect Composite Rating rise to 98 Friday, up from 93 the day before.","url":"https://finance.yahoo.com/m/f70e99d9-c3a5-38d0-911f-032de7017cad/amphastar-pharmaceuticals.html"},{"category":"company","date":1699640152,"headline":"Plenty Of IBD 50 Companies' Earnings Impress, And Some Remain Actionable","id":123797827,"image":"https://media.zenfs.com/en/ibd.com/7ca134ee99bc286172909f42bb4f6d1e","symbol":"AMPH","publisher":"Yahoo","summary":"Consumer stocks got their fair share of Q3 earnings success.  More than 80% of the sector's Q3 earnings have come in above expectations.  Shares now are extended from the 568.47 buy point, underscoring its earnings triumph.","url":"https://finance.yahoo.com/m/d783463d-1698-39e3-882a-bc50a4cbf161/plenty-of-ibd-50-companies%27.html"},{"category":"company","date":1699563900,"headline":"Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference","id":123779469,"image":"https://media.zenfs.com/en/accesswire.ca/90e521a3fdf957b772eef6bc052f6552","symbol":"AMPH","publisher":"Yahoo","summary":"RANCHO CUCAMONGA, CA / ACCESSWIRE / November 9, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi EVP of Corp. Administration, will participate in an Analyst-Moderated fireside chat at ...","url":"https://finance.yahoo.com/news/amphastar-pharmaceuticals-present-jefferies-london-210500950.html"},{"category":"company","date":1699554470,"headline":"Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2023 Earnings Call Transcript","id":123779470,"image":"https://s.yimg.com/ny/api/res/1.2/8LX0Oqg3BP66eppSFmcY4w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/d5dcc4abc1dca2a68167e760bdf3876d","symbol":"AMPH","publisher":"Yahoo","summary":"Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2023 Earnings Call Transcript November 8, 2023 Operator: Greetings and welcome to the Amphastar Pharmaceuticals Third Quarter Earnings Conference Call. [Operator Instructions] Please note that certain statements made during this call regarding matters that are not historical facts, including, but not limited to, management’s outlook or predictions for future periods […]","url":"https://finance.yahoo.com/news/amphastar-pharmaceuticals-inc-nasdaq-amph-182750740.html"},{"category":"company","date":1699537103,"headline":"Q3 2023 Amphastar Pharmaceuticals Inc Earnings Call","id":123779471,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"AMPH","publisher":"Yahoo","summary":"Q3 2023 Amphastar Pharmaceuticals Inc Earnings Call","url":"https://finance.yahoo.com/news/q3-2023-amphastar-pharmaceuticals-inc-133823719.html"},{"category":"company","date":1699524780,"headline":"7 Healthcare Stocks That Are Poised to Become the Next Unicorns","id":123763032,"image":"","symbol":"AMPH","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3204332829"},{"category":"company","date":1699521300,"headline":"Disney, Twilio, TransDigm, Marathon Digital And Other Big Stocks Moving Higher On Thursday","id":123756544,"image":"","symbol":"AMPH","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3204242330"},{"category":"company","date":1699509300,"headline":"Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH), Atara Biotherapeutics (ATRA) and Tempest Therapeutics (TPST)","id":123760983,"image":"","symbol":"AMPH","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3203970491"},{"category":"company","date":1699509240,"headline":"Needham Keeps Their Hold Rating on Amphastar Pharmaceuticals (AMPH)","id":123767059,"image":"","symbol":"AMPH","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3203969602"},{"category":"company","date":1699508520,"headline":"Amphastar: Q3 Earnings Snapshot","id":123767060,"image":"","symbol":"AMPH","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=m5wtbyhjv0"},{"category":"company","date":1699504500,"headline":"Amphastar Pharmaceuticals (AMPH): Assessing the Discrepancy Between Market Price and Intrinsic Value","id":123767061,"image":"","symbol":"AMPH","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3205029384"},{"category":"company","date":1699483145,"headline":"Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2023 Earnings Call Transcript","id":123744814,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"AMPH","publisher":"SeekingAlpha","summary":"Amphastar Pharmaceuticals, Inc. (NASDAQ:NASDAQ:AMPH) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ETCompany ParticipantsDan Dischner - SVP of...","url":"https://seekingalpha.com/article/4649537-amphastar-pharmaceuticals-inc-amph-q3-2023-earnings-call-transcript"},{"category":"company","date":1699477500,"headline":"Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023","id":123749711,"image":"https://media.zenfs.com/en/accesswire.ca/90e521a3fdf957b772eef6bc052f6552","symbol":"AMPH","publisher":"Yahoo","summary":"Reports Net Revenues of $180.6 Million for the Three Months Ended September 30, 2023RANCHO CUCAMONGA, CA / ACCESSWIRE / November 8, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (\"Amphastar\" or the \"Company\") today reported results for the ...","url":"https://finance.yahoo.com/news/amphastar-pharmaceuticals-reports-financial-results-210500140.html"},{"category":"company","date":1699417560,"headline":"Amphastar Pharmaceuticals Non-GAAP EPS of $1.15 beats by $0.46, revenue of $180.6M beats by $6.8M","id":123767064,"image":"","symbol":"AMPH","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3202755361"},{"category":"company","date":1699414800,"headline":"Recap: Amphastar Pharma Q3 Earnings","id":123767065,"image":"","symbol":"AMPH","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3202657794"},{"category":"company","date":1699344360,"headline":"Earnings Preview For Amphastar Pharma","id":123709459,"image":"","symbol":"AMPH","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3199671239"},{"category":"company","date":1699331880,"headline":"Amphastar Pharmaceuticals Q3 2023 Earnings Preview","id":123709460,"image":"","symbol":"AMPH","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3200556042"},{"category":"company","date":1699104905,"headline":"Amphastar Pharmaceuticals' (NASDAQ:AMPH) 42% YoY earnings expansion surpassed the shareholder returns over the past three years","id":123628594,"image":"https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","symbol":"AMPH","publisher":"Yahoo","summary":"It hasn't been the best quarter for Amphastar Pharmaceuticals, Inc. ( NASDAQ:AMPH ) shareholders, since the share price...","url":"https://finance.yahoo.com/news/amphastar-pharmaceuticals-nasdaq-amph-42-133505877.html"},{"category":"company","date":1698869400,"headline":"Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023","id":123555510,"image":"https://media.zenfs.com/en/accesswire.ca/90e521a3fdf957b772eef6bc052f6552","symbol":"AMPH","publisher":"Yahoo","summary":"RANCHO CUCAMONGA, CA / ACCESSWIRE / November 1, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2023 ended September 30, 2023, after the market closes on Wednesday, November ...","url":"https://finance.yahoo.com/news/amphastar-pharmaceuticals-release-third-quarter-201000854.html"}]}